Tag - Ngsx

Books-A-Million Inc. (Nasdaq:BAMM), CNinsure Inc. (Nasdaq:CISG) and Biocryst Pharmaceuticals Inc. (Nasdaq:BCRX) are among the new 52-week highs in Friday's trading among companies with market capitalizations under $1 billion.

Also included among the results: NeurogesX Inc. (Nasdaq:NGSX), Cott Corp. (Nasdaq:COT), ImmunoGen Inc. (Nasdaq:IMGN), DSP Group Inc. (Nasdaq:DSPG), J&J Snack Foods Corp. (Nasdaq:JJSF) and SonicWALL Inc. (Nasdaq:SNWL).

ClickSoftware Technologies Ltd. (Nasdaq:CKSW), NeurogesX Inc. (Nasdaq:NGSX) and Clearwater Paper Corp. (Nasdaq:CLW) are among the new 52-week highs in Wednesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: JMP Group Inc. (Nasdaq:JMP), Health Fitness Corp. (Nasdaq:FIT), Aruba Networks Inc. (Nasdaq:ARUN), Multimedia Games Inc. (Nasdaq:MGAM), Bridgepoint Education Inc. (Nasdaq:BPI) and Rentrak Corp. (Nasdaq:RENT).

Medicinova Inc. (Nasdaq:MNOV), Biocryst Pharmaceuticals Inc. (Nasdaq:BCRX) and JDA Software Group Inc. (Nasdaq:JDAS) are among the new 52-week highs in Tuesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Lannett Co Inc. (Nasdaq:LCI), RINO International Corp. (Nasdaq:RINO), Dorman Products Inc. (Nasdaq:DORM), Intellon Corp. (Nasdaq:ITLN), Fuqi International Inc. (Nasdaq:FUQI) and NeurogesX Inc. (Nasdaq:NGSX).

Calavo Growers Inc. (Nasdaq:CVGW), FiberNet Telecom Group Inc. (Nasdaq:FTGX) and Bridgford Foods Corp. (Nasdaq:BRID) are among the new 52-week highs in Thursday's trading among companies with market capitalizations under $1 billion.

Also included among the results: NeurogesX Inc. (Nasdaq:NGSX), Inspire Pharmaceuticals Inc. (Nasdaq:ISPH), NCI Inc. (Nasdaq:NCIT), Todd Shipyards Corp. (Nasdaq:TOD), Florida Public Utilities Co. (Nasdaq:FPU) and RehabCare Group, Inc. (Nasdaq:RHB).

Wonder Auto Technology Inc (Nasdaq:WATG), United Security Bancshares Inc.(Nasdaq:USBI) and Universal Travel Group (Nasdaq:UTA) are among the new 52-week highs in Thursday's trading among companies with market capitalizations under $1 billion.

Also included among the results: NeurogesX Inc (Nasdaq:NGSX), Orthovita Inc (Nasdaq:VITA), Todd Shipyards Corp (Nasdaq:TOD), ChinaCast Education Corp (Nasdaq:CAST), ICU Medical Inc (Nasdaq:ICUI) and NxStage Medical Inc (Nasdaq:NXTM).

AgFeed Industries Inc. (Nasdaq:FEED),Daktronics Inc. (Nasdaq:DAKT) and Eagle Bulk Shipping Inc. (Nasdaq:EGLE) are among the most actively traded companies in Tuesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: NeurogesX Inc. (Nasdaq:NGSX),Vanda Pharmaceuticals Inc. (Nasdaq:VNDA),IMAX Corp. (Nasdaq:IMAX),Poniard Pharmaceuticals Inc. (Nasdaq:PARD),Omega Navigation Enterprises Inc. (Nasdaq:ONAV) and CommVault Systems Inc. (Nasdaq:CVLT).

KongZhong Corp. (Nasdaq:KONG), Great Southern Bancorp Inc. (Nasdaq:GSBC) and Stein Mart, Inc. (Nasdaq:SMRT) are among the new 52-week highs in Tuesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: SXC Health Solutions Corp. (Nasdaq:SXCI), Symmetricom Inc. (Nasdaq:SYMM), NeurogesX Inc. (Nasdaq:NGSX), STEC Inc. (Nasdaq:STEC), Central Garden & Pet Co. (Nasdaq:CENTA) and Spartan Motors Inc. (Nasdaq:SPAR).

Bridge Bancorp Inc. (Nasdaq:BDGE), ESB Financial Corp. (Nasdaq:ESBF) and NeurogesX Inc. (Nasdaq:NGSX) are among the new 52-week highs in Wednesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: MYR Group Inc. (Nasdaq:MYRG), Central Garden & Pet Co (Nasdaq:CENTA), Cubic Corp (Nasdaq:CUB), Cott Corp (Nasdaq:COT), Bank of Kentucky Financial Corp (Nasdaq:BKYF) and China Holdings Acquisition Corp (Nasdaq:HOL).

This year hasn’t exactly been a banner year for specialty pharmaceutical companies that analysts might have forecasted. Year-to-date, the overall sector has seen a measly 2.2% return, compared with 9% in 2006. Small-cap specialty pharmaceuticals returned just 10.1% year-to-date, compared with a ripe 34.4% return in 2006. The last 30 days in particular have shown considerable underperformance, clocking in at -4.1%.

Despite a disappointing 2007, analyst Angela Larson with Susquehanna Financial said that “[a] robust calendar leaves us room for optimism for 2008.” Looking at 2007, the analyst concedes that the low base incurred this year may mean greater room for growth in the coming year.

Larson says the key catalysts for moving valuation going forward (in order of priority) include, successful FDA approval and launch of new products, successful completion of Phase 3 studies, successful completion of Phase 2 studies that can lead to Phase 3 and partnership discussions, the acquisition of products and the clarity in funds to achieve outlined goals.

Among the companies she covers, Larson says all but two companies are hitting one or more of these milestones in 2008. Small caps Anesiva and POZEN are both expected to launch products that should bring a new market opportunities to their respective companies, Larson says. Additionally, ISTA Pharmaceuticals and Salix have products on tap for 2008 that could, according to Larson, expand or protect the companies’ existing franchises.

Significant news flow on the Phase 3 data release is also expected in 2008, according to Larson, from companies including Allergan, Barrier Therapeutics, Cadence, DURECT, Endo, Inspire, ISTA, NeurogesX, Obagi, POZEN, Salix, Sciele and Shire.

“News events in 2007 have tended to carry greater risk than reward due to the market offering a negative bias on performance and expectations on good news being priced in early,” Larson wrote in a research note today. “However, we believe the news flow is more robust and varied this year, which may help re-cast the group sentiment.”

The small-cap specialty pharmaceuticals Larson has a positive rating on include Barrier Therapeutics (BTRX), Barrier Therapeutics (CADX), ISTA Pharmaceuticals (ISTA), NeurogesX (NGSX), Obagi Medical Products (OMPI) and POZEN (POZN).

China Sunergy Co., Ltd. (Nasdaq: CSUN), Uranium Resources, Inc. (NasdaQ:URRE) and NeurogesX Inc. (Nasdaq: NGSX) are among the most actively traded companies in Friday pre-market trading among those with market capitalizations under $500 million:

Shares of NeurogesX, Inc. (Nasdaq: NGSX) jumped this morning after the biopharmaceutical company announced positive top-line results from its second study of NGX-4010, the company's dermal patch containing chemical TRPV1 agonist in patients with postherpetic neuralgia.

The controlled Phase 3 trial study met its “pre-specified primary endpoint: the reduction in pain from baseline to study weeks 2-8,” according to NeurogesX. This is the second of two successful Phase 3 clinical trials of NGX-4010 for postherpetic neuralgia that the Company has completed in the past year.

NGX-4010 is a dermal patch designed to manage peripheral neuropathic pain.

Postherpetic neuralgia is a condition that affects your nerve fibers and skin. During an initial infection of chickenpox, some of the virus can remain in your system, lying dormant inside nerve cells. Years later, factors such as age, illness, stress or medications can reactivate the virus, causing shingles, or reactivate for no reason.

Shares of NeurogesX gained 18.3%, or $1.30, to $8.41 in late morning trading Tuesday.

Air filters and piping systems maker MFRI, Inc. (Nasdaq: MFRI) said strong sales prompted its first-quarter profit to multiply six times over the year-ago period. The Niles, Ill.-based company reported income for the first quarter ended April 30 was $1 million, or $0.15 per share, up from $151,000, or $0.03 per share, a year earlier. Analysts polled by Thomson Financial predicted earnings of $0.10 per share.

NeurogesX Inc. (Nasdaq: NGSX) announced it has completed enrollment for the third trial phase of its postherpetic neuralgia treatment NGX-4010.

Boosted by increased pricing and operational improvements, Exide Technologies’ (Nasdaq: XIDE) fourth quarter loss narrowed from the year-ago period. The battery maker reported a quarterly loss of $21.6 million, or $0.35 per share, compared with a loss of $76.3 million, or $2.98 per share, a year earlier.

Cano Petroleum, Inc. (AMEX: CFW) said it sold its Rich Valley, Okl. property to a private company for $7.0 million.

Solar energy equipment maker Amtech Systems, Inc. (Nasdaq: ASYS) announced $4.1 million in new orders from Asia. The Tempe, Ariz.-based company said it expects to deliver the orders in six months.

Rock Hill, S.C.-based 3D Systems Corp. (Nasdaq: TDSC) announced its Tangible Express technology will be featured in the July issue of “Plastics Technology” magazine.

These are the biggest percentage gainers in Tuesday's trading among companies with market capitalizations under $500 million:

Medivation, Inc. (Nasdaq: MDVN) announced its Alzheimer’s drug Dimebon significantly improved symptoms over one year and was more effective than a placebo used in a clinical trial.

Neurochem Inc. (Nasdaq: NRMX) reported some positive preliminary data in a Phase III trial of its Alzheimer’s drug tramiprosate, but the Canadian company said it is still working on analysis. Neurochem said it will announce top-line trial results during the second quarter ending June 30.

Private equity group BBAC LLC announced it is taking Back Yard Burgers, Inc. (Nasdaq: BYBI) private for approximately $38 million.

The following are the most actively traded companies in Monday pre-market trading among those with market capitalizations under $500 million:

The major U.S. indices are lower on news of higher yields on U.S. government bonds. At 11:50 a.m. ET the Russell 2000 was down 8.89 points, or 1.06%, to 832.32. The Dow Jones Industrial Average was down 69.81 points, or 0.52%, to 13,395.86.

Shares of PriceSmart, Inc. (Nasdaq: PSMT), which operates U.S.-style membership shopping warehouse clubs in Central America and the Caribbean, are higher on news May store sales increased. Same-warehouse sales (sales at warehouses open more than one year) rose 21.3% for the five weeks ended June 3, compared with the same period of 2006, the San Diego-based company said before the opening bell.

Supercomputer maker Cray Inc. (Nasdaq: CRAY) said Monday morning that revenue from its newest supercomputers will be less than 2007 expectations, possibly leading to a loss for the year.

A story on Yahoo! Finance said Answers Corp. (Nasdaq: ANSW) doesn’t look like it is going to be acquired. Google competitors don’t want to purchase Answers because the New York City-based Internet company, which hasn’t achieved profitability, gets most of its traffic through Google, the story said.

Bionovo Inc.’s (Nasdaq: BNVI) second phase trial for its oral drug MF101 showed positive results for treatment of hot flashes associated with menopause.

These are the biggest percentage losers in Monday's trading among companies with market capitalizations under $500 million: